• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人斯蒂尔病中罕见、更为罕见的肺部受累:一篇综述。

Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

作者信息

Nies Jasper F, Schneider Udo, Krusche Martin

机构信息

Internal Medicine II, University Medical Center Cologne, Cologne, Germany.

Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Front Med (Lausanne). 2022 Sep 16;9:989777. doi: 10.3389/fmed.2022.989777. eCollection 2022.

DOI:10.3389/fmed.2022.989777
PMID:36186767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9522967/
Abstract

Adult-onset Still's disease (AOSD) is a polygenic systemic autoinflammatory disease which is associated with increased morbidity and mortality. Pulmonary involvement is a rare, but serious complication of AOSD. As in AOSD, IL-1b, IL-18, and IL-6 dominate the molecular pathogenesis, which mediate a type 1 and type 3 inflammatory signature of the adaptive immune system. This is evidenced by the success of IL-1- and IL-6 inhibition in the management of AOSD. However, anaphylactic reactions to treatment with IL-1- or IL-6-inhibitors is currently being discussed as a potential trigger for lung involvement inf AOSD, while genetic risk factors have also been identified. Clinically, pulmonary involvement in AOSD can manifest in many different forms. Parenchymal inflammation with peripheral consolidations is the most frequent form while PAH is less common, but often very difficult to manage. This mini-review provides an overview of the pathophysiology as well as the clinical presentation and the diagnostic features of pulmonary involvement in AOSD.

摘要

成人斯蒂尔病(AOSD)是一种多基因系统性自身炎症性疾病,与发病率和死亡率增加相关。肺部受累是AOSD罕见但严重的并发症。与AOSD一样,白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)和白细胞介素-6(IL-6)在分子发病机制中起主导作用,它们介导适应性免疫系统的1型和3型炎症特征。IL-1和IL-6抑制在AOSD治疗中的成功证明了这一点。然而,目前正在讨论IL-1或IL-6抑制剂治疗引起的过敏反应是AOSD肺部受累的潜在触发因素,同时也已确定了遗传风险因素。临床上,AOSD的肺部受累可表现为多种不同形式。伴有外周实变的实质炎症是最常见的形式,而肺动脉高压(PAH)较少见,但通常很难处理。本综述概述了AOSD肺部受累的病理生理学、临床表现和诊断特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c8/9522967/5f217dc2bfb0/fmed-09-989777-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c8/9522967/0fb38e6d76b3/fmed-09-989777-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c8/9522967/5f217dc2bfb0/fmed-09-989777-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c8/9522967/0fb38e6d76b3/fmed-09-989777-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c8/9522967/5f217dc2bfb0/fmed-09-989777-g0002.jpg

相似文献

1
Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.成人斯蒂尔病中罕见、更为罕见的肺部受累:一篇综述。
Front Med (Lausanne). 2022 Sep 16;9:989777. doi: 10.3389/fmed.2022.989777. eCollection 2022.
2
A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.一种针对成年斯蒂尔病并发症肺动脉高压的新型治疗方法:靶向白细胞介素-6。
Int J Rheum Dis. 2014 Mar;17(3):336-40. doi: 10.1111/1756-185X.12324. Epub 2014 Feb 28.
3
Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.生物制剂治疗时代的成人斯蒂尔病(AOSD):细胞因子和临床表现的二分法观点。
Autoimmun Rev. 2014 Nov;13(11):1149-59. doi: 10.1016/j.autrev.2014.08.032. Epub 2014 Aug 27.
4
Interleukin-18: a biomarker with therapeutic potential in adult-onset Still's disease.白细胞介素-18:成人斯蒂尔病中具有治疗潜力的生物标志物。
Expert Rev Clin Immunol. 2022 Aug;18(8):823-833. doi: 10.1080/1744666X.2022.2096592. Epub 2022 Jul 4.
5
Pulmonary arterial hypertension secondary to adult-onset Still's disease: Response to cyclosporine and sildenafil over 15 years of follow-up.成人斯蒂尔病继发肺动脉高压:15年随访中对环孢素和西地那非的反应
Respir Med Case Rep. 2016 Jun 20;19:27-30. doi: 10.1016/j.rmcr.2016.06.007. eCollection 2016.
6
Adult-onset Still's disease.成人斯蒂尔病。
Autoimmun Rev. 2014 Jul;13(7):708-22. doi: 10.1016/j.autrev.2014.01.058. Epub 2014 Mar 19.
7
Parenchymal lung disease in adult onset Still's disease: an emergent marker of disease severity-characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients.成人斯蒂尔病中的肺实质疾病:疾病严重程度的一个新出现的标志物——来自意大利临床与实验风湿病研究小组(GIRRCS)患者队列的特征及预测因素
Arthritis Res Ther. 2020 Jun 22;22(1):151. doi: 10.1186/s13075-020-02245-5.
8
Adult-onset Still's disease with neurological involvement: a single-centre report.成人斯蒂尔病伴神经系统受累:单中心报告。
Rheumatology (Oxford). 2021 Sep 1;60(9):4152-4157. doi: 10.1093/rheumatology/keaa899.
9
Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still's disease.分子遗传学分析在周期性发热综合征中的应用:对成人Still 病诊断的补充作用。
Clin Rheumatol. 2018 Aug;37(8):2021-2026. doi: 10.1007/s10067-018-4178-z. Epub 2018 Jun 17.
10
Serum Interleukin-18 Provides a Clue to the Diagnosis of Adult-Onset Still's Disease: Findings from 6 Japanese Patients with Adult-Onset Still's Disease.血清白细胞介素-18 为成人Still 病的诊断提供线索:6 例成人Still 病患者的研究结果。
J Nippon Med Sch. 2022 Mar 11;89(1):114-118. doi: 10.1272/jnms.JNMS.2022_89-114. Epub 2021 Sep 14.

引用本文的文献

1
Worldwide evaluation of Clinical Practice Strategies (CliPS) for lung involvement in Still's disease within the JIR-CliPS network: a COST action.JIR-CliPS网络内关于斯蒂尔病肺部受累的临床实践策略(CliPS)的全球评估:一项欧洲科学与技术合作组织(COST)行动
Rheumatol Adv Pract. 2025 Jul 3;9(3):rkaf073. doi: 10.1093/rap/rkaf073. eCollection 2025.
2
Non-Classical Complications of Adult-Onset Still's Disease: A Multicenter Spanish Study.成人斯蒂尔病的非典型并发症:一项西班牙多中心研究
J Clin Med. 2025 Jan 6;14(1):285. doi: 10.3390/jcm14010285.
3
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.

本文引用的文献

1
Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review.JAK抑制剂在自身炎症性疾病中的有效性和安全性:一项系统评价。
Front Med (Lausanne). 2022 Jun 27;9:930071. doi: 10.3389/fmed.2022.930071. eCollection 2022.
2
Development and Implementation of the AIDA International Registry for Patients With Still's Disease.斯蒂尔病患者国际AIDA注册库的建立与实施
Front Med (Lausanne). 2022 Apr 7;9:878797. doi: 10.3389/fmed.2022.878797. eCollection 2022.
3
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis.
白细胞介素 (IL)-1/IL-6 抑制剂相关嗜酸性粒细胞增多和全身症状药物反应 (DReSS) 在炎症性疾病中的作用。
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2996-3013.e7. doi: 10.1016/j.jaip.2024.07.002. Epub 2024 Aug 15.
4
Initial Respiratory System Involvement in Juvenile Idiopathic Arthritis with Systemic Onset Is a Marker of Interstitial Lung Disease: The Results of Retrospective Cohort Study Analysis.幼年特发性关节炎全身型起病时呼吸系统的初始受累是间质性肺疾病的一个标志:一项回顾性队列研究分析结果
J Clin Med. 2024 Jun 29;13(13):3843. doi: 10.3390/jcm13133843.
血清蛋白质组分析鉴定系统性幼年特发性关节炎及相关肺部疾病中的不同炎症程序和生物标志物。
Arthritis Rheumatol. 2022 Jul;74(7):1271-1283. doi: 10.1002/art.42099. Epub 2022 May 31.
4
Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine.辉瑞-BNT162b2 mRNA 新冠疫苗接种后发生成人斯蒂尔病。
J Korean Med Sci. 2021 Dec 27;36(50):e344. doi: 10.3346/jkms.2021.36.e344.
5
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.严重的迟发性超敏反应与白细胞介素-1 和白细胞介素-6 抑制剂相关,与常见的 HLA-DRB1*15 等位基因有关。
Ann Rheum Dis. 2022 Mar;81(3):406-415. doi: 10.1136/annrheumdis-2021-220578. Epub 2021 Nov 17.
6
[Still's syndrome-similarities and differences between the juvenile and adult forms].[斯蒂尔病——青少年型和成人型的异同]
Z Rheumatol. 2022 Feb;81(1):22-27. doi: 10.1007/s00393-021-01117-w. Epub 2021 Nov 4.
7
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs.通过标志性细胞因子中心重塑免疫介导的炎症性疾病
N Engl J Med. 2021 Aug 12;385(7):628-639. doi: 10.1056/NEJMra1909094.
8
Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.从绝望中拯救:成人斯蒂尔病伴危及生命的间质性肺病和巨噬细胞活化:托珠单抗成功治疗
Z Rheumatol. 2022 May;81(4):335-338. doi: 10.1007/s00393-021-01063-7. Epub 2021 Aug 10.
9
First manifestation of adult-onset Still's disease after COVID-19.新型冠状病毒肺炎后成人斯蒂尔病的首发表现
Lancet Rheumatol. 2021 May;3(5):e319-e321. doi: 10.1016/S2665-9913(21)00072-2. Epub 2021 Mar 26.
10
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease.成人类风湿关节炎患者康纳单抗疗效的真实世界数据。
Mediators Inflamm. 2020 Oct 15;2020:8054961. doi: 10.1155/2020/8054961. eCollection 2020.